医学
围手术期
外科
临床试验
新辅助治疗
胰腺癌
内科学
随机对照试验
梅德林
癌症
肿瘤科
化疗
重症监护医学
总体生存率
全身疗法
普通外科
风险评估
胰腺切除术
作者
Ruth A.L. Willems,Aniek E. van Diepen,Esther N. Dekker,Quisette P. Janssen,Jacob L. van Dam,Nynke Michiels,Casper W.F. van Eijck,K. Hermans,Bert A. Bonsing,Koop P. Bosscha,S. Bouwense,Olivier R. Busch,Hugo ten Cate,Peter-Paul L.O Coene,Casper H.J. van Eijck,Nick van Es,Erwin van der Harst,Ignace H.J.T. de Hingh,Tom M. Karsten,Geert Kazemier
摘要
VTE occurred in 9% of patients with (borderline) resectable PDAC undergoing (neo)adjuvant treatment in the year after random assignment and was associated with decreased OS. These results underscore the need for standardized reporting of thromboembolic events in clinical trials and future studies assessing the potential benefits of thromboprophylaxis during neoadjuvant therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI